1. JHALAK MEHTA
11217 Melvin Ct | Laurel, MD 20723 | (240) 461-1802 | Mehta.Jhalak@gmail.com
OBJECTIVE
Experienced research professional with expertise in process procedure development and strategic planning
seeking a position in the research arena.
AREAS OF EXCELLENCE
Molecular Medicine
Summary Preparation
Research and Analysis
Seminar Presentations
Grant Allocation and
Application Preparation
PROFESSIONAL EXPERIENCE
 Research Assistant – University of Maryland September 2004 – December 2008
o Implemented molecular biology techniques including Western immunoblot analysis and
immunoprecipitations, mammalian cell culture techniques involving human breast cancer cell lines,
and mouse xenograft models in immunodeficient mice for evaluation of possible anti-cancer
therapies.
o Performed data analysis using Graph Pad prism and Sigmaplot analysis packages.
o Research focused on Oncopharmacology.
 QA Analyst – Cadila Healthcare Pvt. Ltd. 2003
o Studied the manufacturing and packaging of various solid and liquid dosage forms.
o Worked in the Quality Control and Quality Assurance section learning various aspects of testing
and labeling procedures.
 Hospital Pharmacist – Civil Hospital Outpatient department 1999 – 2002
o Work involved filling and dispensing prescriptions and researching possible drug interactions.
o Also ensuring safe and proper storage of medical products.
o Counseling patients and their caretakers on dosage and administration of drug treatments.
EDUCATION
Masterof Science in Molecular Physiology and Pharmacology, 2009
University of Maryland
Bachelor of Science in Pharmacy, 2003
Gujarat University
Diploma in Pharmacy, 1999
Gujarat University
MISCELLANOUS
US Citizen

2. PUBLICATIONS AND PRESENTATIONS
 Vincent C.O. Njar, Lalji Gediya, Puranik Purushottamachar, Pankaj Chopra, Tadas Sean Vasaitis,
Aakanksha Khandelwal, Jhalak Mehta, Carlic Huynh, Aashvini Belosay and Jyoti Patel. Retinoic acid
metabolism Blocking agents (RAMBAs) for treatment of cancer and dermatological diseases.
Bioorganic Medicinal Chemistry. 2006 Jul 1; 14(13):4323-40.
 JB Patel, J Mehta, A Belosay, G Sabnis, A Khandelwal, AMH Brodie, DR Soprano and VCO Njar.
Novel retinoic acid metabolism blocking agents have potent inhibitory activities on human breast cancer
cells and tumor growth. British Journal of Cancer (2007) 96, 1204-1215
 Gediya LK, Khandelwal A, Patel J, Belosay A, Sabnis G, Mehta J, Purushottamachar P, Njar VC.
Design, synthesis, and evaluation of novel mutual prodrugs (hybrid drugs) of all-trans-retinoic acid and
histone deacetylase inhibitors with enhanced anticancer activities in breast and prostate cancer cells in
vitro. Journal of Medicinal Chemistry. 2008 Jul 10; 51(13):3895-904.
 Lalji K. Gediya, Jhalak Mehta, Aakanksha Khandelwal, Puranik Purushottamachar and Vincent C.O.
Njar;, Mutual prodrugs of all-trans retinoic acid and histone deacetylase inhibitors: Potent anticancer
agents. Poster Presentation: 233rd American Chemical Society National Meeting, March 2007, Chicago,
IL
 Lalji K. Gediya, Jyoti B. Patel, Purushottamachar P. Puranik, Jhalak Mehta and Vincent CO. Njar;, A
new facile and expeditious one pot synthesis of CI -994 and its inhibitory effect alone or in combination
with ATRA/RAMBAs on the growth of MDA-MB-231 human breast cancer cells. Poster Presentation :
231st American Chemical Society National Meeting, March 2006, Atlanta, GA.